BISAGLIA, MARCO
BISAGLIA, MARCO
Dipartimento di Biologia - DiBio
A Topological Model of the Interaction between alpha-Synuclein and SDS Micelles.
2005 Bisaglia, Marco; Tessari, Isabella; L., Pinato; Bellanda, Massimo; S., Giraudo; M., Fasano; Bergantino, Elisabetta; Bubacco, Luigi; Mammi, Stefano
Activation of RegB endoribonuclease by S1 ribosomal protein requires an 11 nt conserved sequence
2006 Durand, S; Richard, G; Bisaglia, Marco; Laalami, S; Bontems, F; Uzan, M.
Activation of the Nrf2 Pathway as a Therapeutic Strategy for ALS Treatment
2022 Arslanbaeva, L.; Bisaglia, M.
Activation of the RegB Endoribonuclease by the S1 Ribosomal Protein Is Due to Cooperation between the S1 Four C-terminal Modules in a Substrate-dependant Manner
2003 Bisaglia, Marco; Laalami, S.; Uzan, M.; Bontems, F.
alpha-Synuclein overexpression increases dopamine toxicity in BE(2)-M17 cells
2010 Bisaglia, Marco; Greggio, Elisa; Maric, D; Miller, Dw; Cookson, Mr; Bubacco, Luigi
Analysis of the Catecholaminergic Phenotype in Human SH-SY5Y and BE(2)-M17 Neuroblastoma Cell Lines upon Differentiation
2015 Filograna, Roberta; Civiero, Laura; Ferrari, Vanni; Codolo, Gaia; Greggio, Elisa; Bubacco, Luigi; Beltramini, Mariano; Bisaglia, Marco
Anti-oxidants in Parkinson's disease therapy: a critical point of view
2016 Filograna, Roberta; Beltramini, Mariano; Bubacco, Luigi; Bisaglia, Marco
Antioxidant Therapy in Parkinson's Disease: Insights From Drosophila melanogaster
2020 DE LAZZARI, Federica; Sandrelli, Federica; Whitworth, ALEXANDER JAMES; Bisaglia, Marco
Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease?
2014 Bisaglia, Marco; Filograna, Roberta; Beltramini, Mariano; Bubacco, Luigi
Binding Interactions of Agents That Alter α-Synuclein Aggregation.
2015 Sivanesam, K; Byrne, A; Bisaglia, Marco; Bubacco, Luigi; Andersen, N.
Biophysical groundwork as a hinge to unravel the biology of α-synuclein aggregation and toxicity.
2014 Plotegher, Nicoletta; Greggio, Elisa; Bisaglia, Marco; Bubacco, Luigi
Broken helix in vesicle and micelle-bound alpha-synuclein: Insights from site-directed spin labeling-EPR experiments and MD simulations
2008 Bortolus, Marco; Tombolato, Fabio; Tessari, Isabella; Bisaglia, Marco; Mammi, Stefano; Bubacco, Luigi; Ferrarini, Alberta; Maniero, ANNA LISA
Circadian Rhythm Abnormalities in Parkinson's Disease from Humans to Flies and Back
2018 DE LAZZARI, Federica; Bisaglia, Marco; Zordan, MAURO AGOSTINO; Sandrelli, Federica
Cloning, expression, purification, and spectroscopic analysis of the fragment 57-102 of human alpha-synuclein
2005 Bisaglia, Marco; Trolio, Alessandra; Tessari, Isabella; Bubacco, Luigi; Mammi, Stefano; Bergantino, Elisabetta
Copper Binding and Redox Activity of α-Synuclein in Membrane-Like Environment
2023 Bacchella, C.; Camponeschi, F.; Kolkowska, P.; Kola, A.; Tessari, I.; Baratto, M. C.; Bisaglia, M.; Monzani, E.; Bubacco, L.; Mangani, S.; Casella, L.; Dell'Acqua, S.; Valensin, D.
Copper Ions and Parkinson's Disease: Why Is Homeostasis So Relevant?
2020 Bisaglia, Marco; Bubacco, Luigi
Covalent alfa-synuclein dimers: chemico-physical and aggregation properties
2012 Pivato, Micaela; DE FRANCESCHI, Giorgia; Laura, Tosatto; Erica, Frare; Dhruv, Kumar; Daniel, Aioanei; Marco, Brucale; Tessari, Isabella; Bisaglia, Marco; Bruno, Samori; POLVERINO DE LAURETO, Patrizia; Bubacco, Luigi
Designed hairpin peptides interfere with amyloidogenesis pathways: fibril formation and cytotoxicity inhibition, interception of the preamyloid state.
2011 Huggins, Kn; Bisaglia, Marco; Bubacco, Luigi; Tatarek Nossol, M; Kapurniotu, A; Andersen, Nh
Diabetes Mellitus as a Risk Factor for Parkinson's Disease: a Molecular Point of View
2018 Biosa, Alice; Outeiro, Tiago F.; Bubacco, Luigi; Bisaglia, Marco
DJ-1 and SOD1 Act Independently in the Protection against Anoxia in Drosophila melanogaster
2022 DE LAZZARI, Federica; Agostini, Francesco; Doni, Davide; Malacrida, Sandro; Zordan, Mauro A.; Costantini, Paola; Bubacco, Luigi; Sandrelli, Federica; Bisaglia, Marco